02453.HK
Concord Healthcare Grp Co Ltd
HKSE · Healthcare · Medical - Care Facilities · CN
HKD 0.77
−5.52%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 883.3M | 448.0M | 388.3M | 538.6M | 472.2M |
| Cost of Revenue | 812.9M | 416.9M | 455.6M | 603.7M | 746.5M |
| Gross Profit | 70.3M | 31.1M | (67.2M) | (65.1M) | (197.5M) |
| Operating Expenses | |||||
| R&D Expense | 56.4M | 27.4M | 31.2M | 36.4M | 41.3M |
| SG&A Expense | 490.7M | 186.6M | 259.4M | 253.0M | 274.0M |
| General & Admin Expense | 265.2M | 133.8M | 210.5M | 197.0M | 213.1M |
| Selling & Marketing Expense | 76.6M | 52.7M | 48.9M | 56.0M | 60.9M |
| Other Expenses | 22.2M | 49.3M | 39.8M | (831.0K) | 43.5M |
| Total Operating Expenses | 569.3M | 263.3M | 330.3M | 288.6M | 358.8M |
| Cost and Expenses | 1.4B | 680.2M | 759.5M | 892.3M | 949.7M |
| Operating Income (EBIT) | (476.5M) | (232.2M) | (371.2M) | (353.7M) | (477.6M) |
| Non-Operating | |||||
| Interest Income | — | 658.5K | 733.0K | 7.3M | 7.8M |
| Interest Expense | 237.3M | 120.3M | 109.3M | 108.0M | 274.5M |
| Net Interest Income | (237.3M) | (119.7M) | (108.5M) | (100.7M) | (266.7M) |
| Other Non-Op Income/Expense | (184.4M) | (69.8M) | (114.6M) | (78.9M) | (169.6M) |
| Non-Operating Income (excl Interest) | (64.1M) | — | (62.7M) | (29.1M) | (7.8M) |
| EBT (Pre-Tax Income) | (683.4M) | (302.0M) | (485.8M) | (432.6M) | (647.2M) |
| Income Tax Expense | (967.7K) | (4.1M) | (1.0M) | (6.2M) | (9.9M) |
| Bottom Line | |||||
| Net Income | (592.9M) | (250.0M) | (443.2M) | (373.1M) | (541.4M) |
| Earnings from Cont. Ops | (688.6M) | (297.9M) | (484.8M) | (426.4M) | (637.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (600.8M) | (250.0M) | (443.2M) | (373.1M) | (541.4M) |
| Per Share | |||||
| Basic EPS | (HK$0.80) | (HK$0.33) | (HK$0.62) | (HK$0.56) | (HK$0.76) |
| Diluted EPS | (HK$0.81) | (HK$0.33) | (HK$0.62) | (HK$0.56) | (HK$0.76) |
| Revenue Per Share | HK$1.13 | HK$0.60 | HK$0.54 | HK$0.81 | HK$0.66 |
| Shares | |||||
| Basic Shares Outstanding | 783.7M | 747.9M | 715.5M | 664.7M | 716.3M |
| Diluted Shares Outstanding | 794.5M | 747.9M | 715.5M | 664.7M | 716.3M |
| Profitability Metrics | |||||
| EBITDA | (215.1M) | (64.0M) | (194.5M) | (172.6M) | (355.5M) |
| D&A | 202.7M | 149.1M | 114.1M | 152.0M | 114.3M |
| EBIT | (417.8M) | (213.2M) | (308.5M) | (324.6M) | (469.8M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026